144 related articles for article (PubMed ID: 15778121)
1. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
Molnar V; Garai J
Int Immunopharmacol; 2005 May; 5(5):849-56. PubMed ID: 15778121
[TBL] [Abstract][Full Text] [Related]
2. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
3. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
4. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase.
Rosengren E; Aman P; Thelin S; Hansson C; Ahlfors S; Björk P; Jacobsson L; Rorsman H
FEBS Lett; 1997 Nov; 417(1):85-8. PubMed ID: 9395080
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
6. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-inducible uterine flavonoid binding sites: is it time to reconsider?
Garai J; Adlercreutz H
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):377-81. PubMed ID: 15145447
[TBL] [Abstract][Full Text] [Related]
9. Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
Sarkar S; Siddiqui AA; Mazumder S; De R; Saha SJ; Banerjee C; Iqbal MS; Adhikari S; Alam A; Roy S; Bandyopadhyay U
J Agric Food Chem; 2015 May; 63(20):4988-98. PubMed ID: 25929447
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E is a MIF Inhibitor.
Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
Kim KW; Kim HR
Korean J Intern Med; 2016 Jul; 31(4):634-42. PubMed ID: 27169879
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
[TBL] [Abstract][Full Text] [Related]
15. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Bilsborrow JB; Doherty E; Tilstam PV; Bucala R
Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
[No Abstract] [Full Text] [Related]
17. Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Kostevich VA; Sokolov AV; Grudinina NA; Zakharova ET; Samygina VR; Vasilyev VB
Biometals; 2015 Oct; 28(5):817-26. PubMed ID: 26091949
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
[TBL] [Abstract][Full Text] [Related]
19. Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
He M; Metz C; Cheng KF; Ling J; Coleman T; VanPatten S; Al-Abed Y
Arch Pharm (Weinheim); 2014 Feb; 347(2):104-7. PubMed ID: 24243226
[TBL] [Abstract][Full Text] [Related]
20. MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
Bloom J; Sun S; Al-Abed Y
Expert Opin Ther Targets; 2016 Dec; 20(12):1463-1475. PubMed ID: 27762152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
